These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 193512)

  • 1. Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung.
    Kreutner W; Sherwood JE
    Biochem Pharmacol; 1977 May; 26(10):951-4. PubMed ID: 193512
    [No Abstract]   [Full Text] [Related]  

  • 2. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue.
    Green D; Guy G; Moore JB
    Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.
    Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A
    Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs.
    Davis CW; Kuo JF
    Biochim Biophys Acta; 1976 Sep; 444(2):554-62. PubMed ID: 183829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vivo and in vitro properties of cyclic adenosine 3':5'-monophosphate phosphodiesterase of amphibian oocytes.
    Allende CC; Bravo R; Allende JE
    J Biol Chem; 1977 Jul; 252(13):4662-6. PubMed ID: 194890
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
    Egrie JC; Siegel FL
    Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect?
    Townley RG
    J Lab Clin Med; 1993 Jan; 121(1):15-7. PubMed ID: 8381147
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.
    Kapui Z; Schaeffer P; Mikus EG; Boronkay E; Gyürky J; Herbert JM; Pascal M
    Arzneimittelforschung; 1999 Aug; 49(8):685-93. PubMed ID: 10483515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenosine 3',5'-cyclic monophosphate phosphodiesterase in guinea-pig lung--properties and effect of adrenergic drugs.
    Hitchcock M
    Biochem Pharmacol; 1973 Apr; 22(8):959-69. PubMed ID: 4348394
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization.
    King LE; Solomon SS; Hasimoto K
    J Invest Dermatol; 1975 Jun; 64(6):390-6. PubMed ID: 237964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on BB-1502, a new bronchodilator.
    Kamei H; Hirano M; Kawano K; Murata S; Imanishi H; Kawaguchi H
    Jpn J Pharmacol; 1981 Jun; 31(3):333-46. PubMed ID: 6273627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent cyclic nucleotide phosphodiesterase from brain: comparison of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate as substrates.
    Brostrom CO; Wolff DJ
    Arch Biochem Biophys; 1976 Jan; 172(1):301-11. PubMed ID: 175742
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-alpha formation with phosphodiesterase 4 (PDE4) selective inhibitors.
    Muise ES; Chute IC; Claveau D; Masson P; Boulet L; Tkalec L; Pon DJ; Girard Y; Frenette R; Mancini JA
    Biochem Pharmacol; 2002 Apr; 63(8):1527-35. PubMed ID: 11996895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation of serum-induced changes in cyclic nucleotide levels in cultured fibroblasts by cyclic nucleotide phosphodiesterase.
    Pledger WJ; Thompson WJ; Strada SJ
    Nature; 1975 Aug; 256(5520):729-31. PubMed ID: 168501
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase].
    Sobolev AS; Orekhov AN; Dhirkov IuIu; Kudriashov IuB
    Dokl Akad Nauk SSSR; 1975 Sep; 224(3):713-6. PubMed ID: 173507
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the inhibition of phosphodiesterase activity and allergic histamine release by disodium cromoglycate and compound I.C.I. 74917.
    Barrett-Bee K; Henderson W
    Biochem Soc Trans; 1976; 4(4):699-701. PubMed ID: 63402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.